Cargando…
Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing
Autores principales: | Mancini, Laura, Casagranda, Stefano, Gautier, Guillaume, Peter, Philippe, Lopez, Bruno, Thorne, Lewis, McEvoy, Andrew, Miserocchi, Anna, Samandouras, George, Kitchen, Neil, Brandner, Sebastian, De Vita, Enrico, Torrealdea, Francisco, Rega, Marilena, Schmitt, Benjamin, Liebig, Patrick, Sanverdi, Eser, Golay, Xavier, Bisdas, Sotirios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165277/ https://www.ncbi.nlm.nih.gov/pubmed/35412055 http://dx.doi.org/10.1007/s00259-022-05798-6 |
Ejemplares similares
-
CEST MRI provides amide/amine surrogate biomarkers for treatment-naïve glioma sub-typing
por: Mancini, Laura, et al.
Publicado: (2022) -
Diagnostic accuracy of dynamic contrast‐enhanced perfusion MRI in stratifying gliomas: A systematic review and meta‐analysis
por: Okuchi, Sachi, et al.
Publicado: (2019) -
GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas
por: Bender, Benjamin, et al.
Publicado: (2021) -
Quantitative CEST imaging of amide proton transfer in acute ischaemic stroke
por: Msayib, Y., et al.
Publicado: (2019) -
Role of diffusional kurtosis imaging in grading of brain gliomas: a protocol for systematic review and meta-analysis
por: Abdalla, Gehad, et al.
Publicado: (2018)